Autophagy and liver cancer

被引:58
作者
Chao, Xiaojuan [1 ]
Qian, Hui [1 ]
Wang, Shaogui [1 ]
Fulte, Sam [1 ]
Ding, Wen-Xing [1 ]
机构
[1] Univ Kansas, Dept Pharmacol Toxicol & Therapeut, Med Ctr, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA
关键词
Alcohol; mTOR; Nrf2; p62; TFEB; ENDOPLASMIC-RETICULUM STRESS; PANCREATIC STELLATE CELLS; TRANSCRIPTION FACTOR NRF2; HEPATITIS-B-VIRUS; PROTEIN-KINASE-C; HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; OXIDATIVE STRESS; PERSISTENT ACTIVATION; KEAP1-NRF2; PATHWAY;
D O I
10.3350/cmh.2020.0169
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Autophagy is a highly conserved catabolic process that degrades cytosolic proteins and organelles via formation of autophagosomes that fuse with lysosomes to form autolysosomes, whereby autophagic cargos are degraded. Numerous studies have demonstrated that autophagy plays a critical role in the regulation of liver physiology and homeostasis, and impaired autophagy leads to the pathogenesis of various liver diseases such as viral hepatitis, alcohol associated liver diseases (AALD), non-alcoholic fatty liver diseases (NAFLD), and liver cancer. Recent evidence indicates that autophagy may play a dual role in liver cancer: inhibiting early tumor initiation while promoting progression and malignancy of already formed liver tumors. In this review, we summarized the progress of current understanding of how hepatic viral infection, alcohol consumption and diet-induced fatty liver diseases impair hepatic autophagy. We also discussed how impaired autophagy promotes liver tumorigenesis, and paradoxically how autophagy is required to promote the malignancy and progression of liver cancer. Understanding the molecular mechanisms underlying how autophagy differentially affects liver cancer development and progression may help to design better therapeutic strategies for prevention and treatment of liver cancer.
引用
收藏
页码:606 / 617
页数:12
相关论文
共 134 条
  • [1] The mammalian target of rapamycin signaling pathway: Twists and turns in the road to cancer therapy
    Abraham, Robert T.
    Gibbons, James J.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (11) : 3109 - 3114
  • [2] p62+ Hyaline Inclusions in Intrahepatic Cholangiocarcinoma Associated With Viral Hepatitis or Alcoholic Liver Disease
    Aishima, Shinichi
    Fujita, Nobuhiro
    Mano, Yohei
    Iguchi, Tomohiro
    Taketomi, Akinobu
    Maehara, Yoshihiko
    Oda, Yoshinao
    Tsuneyoshi, Masazumi
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) : 457 - 465
  • [3] A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)
    Argani, P
    Lui, MY
    Couturier, J
    Bouvier, R
    Fournet, JC
    Ladanyi, M
    [J]. ONCOGENE, 2003, 22 (34) : 5374 - 5378
  • [4] Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury
    Arriazu, Elena
    Ge, Xiaodong
    Leung, Tung-Ming
    Magdaleno, Fernando
    Lopategi, Aritz
    Lu, Yongke
    Kitamura, Naoto
    Urtasun, Raquel
    Theise, Neil
    Antoine, Daniel J.
    Nieto, Natalia
    [J]. GUT, 2017, 66 (06) : 1123 - 1137
  • [5] Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys
    Baba, Masaya
    Furihata, Mutsuo
    Hong, Seung-Beom
    Tessarollo, Lino
    Haines, Diana C.
    Southon, Eileen
    Patel, Vishal
    Igarashi, Peter
    Alvord, W. Gregory
    Leighty, Robert
    Yao, Masahiro
    Bernardo, Marcelino
    Ileva, Lilia
    Choyke, Peter
    Warren, Michelle B.
    Zbar, Berton
    Linehan, W. Marston
    Schmidt, Laura S.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (02): : 140 - 154
  • [6] Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia
    Bao, Jintao
    Zheng, Liangjun
    Zhang, Qi
    Li, Xinya
    Zhang, Xuefei
    Li, Zeyang
    Bai, Xue
    Zhang, Zhong
    Huo, Wei
    Zhao, Xuyang
    Shang, Shujiang
    Wang, Qingsong
    Zhang, Chen
    Ji, Jianguo
    [J]. PROTEIN & CELL, 2016, 7 (06) : 417 - 433
  • [7] Autophagy Inhibition Delays Early but Not Late-Stage Metastatic Disease
    Barnard, Rebecca A.
    Regan, Daniel P.
    Hansen, Ryan J.
    Maycotte, Paola
    Thorburn, Andrew
    Gustafson, Daniel L.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 358 (02) : 282 - 293
  • [8] Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma
    Bartolini, Desiree
    Dallaglio, Katiuscia
    Torquato, Pierangelo
    Piroddi, Marta
    Galli, Francesco
    [J]. TRANSLATIONAL RESEARCH, 2018, 193 : 54 - 71
  • [9] PTEN and the PI3-Kinase Pathway in Cancer
    Chalhoub, Nader
    Baker, Suzanne J.
    [J]. ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 : 127 - 150
  • [10] Chao Xiaojuan, 2019, Adv Pharmacol, V85, P109, DOI 10.1016/bs.apha.2019.01.008